Quantbot Technologies LP Myovant Sciences Ltd. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$7.78 - $14.69 $60,139 - $113,553	7,730 New	7,730 $96,000
Q2 2021 Aug 12, 2021	SELL	$17.07 - $24.56 $23,898 - $34,384	-1,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$20.46 - $25.18 $28,644 - $35,252	1,400 New	1,400 $28,000
Q4 2020 Feb 12, 2021	SELL	$13.8 - $27.62 $11,040 - $22,096	-800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.05 - $22.6 $11,240 - $18,080	800 New	800 $11,000
Q1 2020 May 13, 2020	SELL	$6.55 - $14.76 $2,620 - $5,904	-400 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$4.2 - $19.21 $1,680 - $7,684	400 New	400 $6,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.